NXS — Next Science Cashflow Statement
0.000.00%
- AU$29.22m
- AU$30.50m
- $22.82m
- 31
- 31
- 20
- 17
Annual cashflow statement for Next Science, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | -14.9 | -17.8 | -22.4 | -35.2 | -30.7 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -11.9 | -8.26 | -11.8 | -15.1 | -7.96 |
Capital Expenditures | -0.687 | -0.717 | -0.476 | -0.884 | -0.589 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | — | — | — | -0 | 0 |
Purchase of Investments | |||||
Cash from Investing Activities | -0.687 | -0.717 | -0.476 | -0.884 | -0.589 |
Financing Cash Flow Items | -0.388 | -0.006 | -0.386 | -0.638 | 0.003 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 10.7 | 1.43 | 10.2 | 20.1 | 1.75 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1.57 | -7.97 | -2.26 | 4.17 | -7.56 |